Form 4 for OGN Organon & Co.
Accepted 2023-05-08 00:00:00 ET · period of report 2023-05-04 · accession 0001209191-23-028095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-08 | 2023-05-04 | OGN | Ali Kevin | CEO, Dir | M - OptEx | — | +22.2K | 62.9K | +54% | — |
| D | 2023-05-08 | 2023-05-04 | OGN | Ali Kevin | CEO, Dir | F - Tax | $24.24 | -12.3K | 50.6K | -19% | -$297.0K |
| D | 2023-05-08 | 2023-05-04 | OGN | Ali Kevin | CEO, Dir | M - OptEx | $0.00 | -22.2K | 22.2K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-04 | M | A | 22,158 | — | 62,873 | D | — | — | (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024. |
| 2 | Common | Common Stock | 2023-05-04 | F | D | 12,254 | $24.24 | 50,619 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-05-04 | M | D | 22,158 | $0.00 | 22,161 | D | — · 2023-05-04 to 2024-05-04 | 22,158 Common Stock | (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024. |